Table 2.
Carperitide group | Non-Carperitide group | p value | ||
---|---|---|---|---|
Number | 63 | 65 | ||
Hospital death | 1 (1.6%) | 8 (12.3%) | 0.018 | |
Mortality within 2 years after surgery | 6 | 15 | 0.055 | |
MACCE within 2 years after surgery | 6 | 21 | 0.002 | |
Procedure | ||||
CABG (on pump: OPCAB) | 44 (42:2) | 41 (40:1) | ||
AVR | 3 | 10 | ||
MVR | 0 | 1 | ||
Asc-Ao replacement | 0 | 3 | ||
CABG + valve surgery | 12 | 6 | ||
CABG + Dor | 1 | 0 | ||
AVR + Maze | 1 | 0 | ||
AVR + MVR | 0 | 2 | ||
AVR + MVR + Maze | 0 | 1 | ||
AVR + MVR + TAP | 0 | 1 | ||
AVR + Asc-Ao replacement | 1 | 0 | ||
AVR + MVR + Asc-Ao replacement | 1 | 0 | ||
Numbers of distal anastomoses | 2.68 ± 0.85 | 2.42 ± 0.99 | 0.004 | |
ACCT (min) | 75.2 ± 63.3 | 82.7 ± 56.3 | 0.314 | |
ACCT >90 min | 15 (24%) | 23 (35%) | 0.152 | |
CPBT (min) | 141.3 ± 66.3 | 146.6 ± 64.3 | 0.530 | |
CPBT >180 min | 9 (14%) | 18 (28%) | 0.063 | |
Dopamine use | 47 (75%) | 50 (79%) | 0.759 | |
Dobutamine use | 31 (49%) | 34 (52%) | 0.726 | |
Epinephrine use | 4 (6%) | 12 (18%) | 0.038 | |
Norepinephrine use | 9 (14%) | 21 (32%) | 0.016 | |
Landiolol hydrochloride | 18 (29%) | 20 (31%) | 0.786 | |
Preoperative AF | 2 (3%) | 1 (2%) | 0.541 | |
POAF | 9 (14.8%) | 34 (53.1%) | <0.0001 | |
Weaning from respirator (days) | 1.03 ± 1.15 | 2.04 ± 3.20 | 0.022 | |
Resuming dialysis (days) | 1.71 ± 0.78 | 1.27 ± 0.57 | <0.0001 | |
Urine volume (Oliguria case) | ||||
POD 1 | 312.8 ± 721.0 | 29.3 ± 89.0 | 0.002 | |
POD 2 | 346.0 ± 808.8 | 38.8 ± 123.1 | 0.003 | |
POD 3 | 356.1 ± 852.3 | 35.8 ± 98.6 | 0.003 | |
Disturbance of consciousness | 3 (5%) | 6 (9%) | 0.323 | |
Hospital stay (days) | 15.8 ± 10.0 | 23.9 ± 24.1 | 0.015 |
MACCE: major adverse cardiac and cerebrovascular events; CABG: coronary artery bypass grafting; OPCAB: off pump coronary artery bypass; AVR: aortic valve replacement; MVR: mitral valve replacement; Asc-Ao: ascending aorta; TAP: tricuspid valve annuloplasty; ACCT: aortic cross-clamping tine; CPBT: cardiopulmonary bypass time; AF: atrial fibrillation; POAF: postoperative atrial fibrillation; POD: postoperative day